RMD

ResMed

Healthcare Medical Instruments & Supplies NYSE

About the company

ResMed, a leading global company in the respiratory care device industry, has been a key player in the treatment of sleep apnea. With a focus on developing and supplying flow generators, masks, and accessories, the company has contributed significantly to addressing the growing demand for sleep apnea solutions. One of the factors driving the growth of the sleep apnea market is the increasing diagnosis of this condition. As awareness improves and medical advancements are made, more individuals are being diagnosed with sleep apnea, creating a larger customer base for companies like ResMed. Furthermore, the ageing population and the rising prevalence of obesity are also significant contributors to the increasing demand for respiratory care devices. As these demographic factors continue to shape the global healthcare landscape, ResMed is well-positioned to benefit from the structurally growing market. Geographically, ResMed generates the majority of its revenue from the Americas, which accounts for about two-thirds of its total earnings. However, it also has a significant presence in other regions, especially Europe, Japan, and Australia. This distribution of revenue across multiple regions enables the company to diversify its risk and take advantage of different market dynamics and opportunities around the globe. To stay ahead of the competition and meet the evolving needs of patients, ResMed has been actively focusing on digital health solutions. Recognizing the significance of technological advancements and the value they bring to the healthcare industry, ResMed has made strategic developments and acquisitions in the digital health space. By leveraging digital technologies, the company aims to differentiate itself by providing comprehensive and actionable clinical data that can be utilized by patients, medical care advisors, and payers in the out-of-hospital setting. ResMed's efforts in the digital health space are aimed at enhancing patient care and improving treatment outcomes. By incorporating digital solutions into their respiratory care devices, the company enables patients to track their progress, monitor their therapy, and gain insights into their sleep patterns. This self-management approach empowers patients to take an active role in managing their condition, leading to better adherence and overall health outcomes. Moreover, ResMed's digital health initiatives also benefit medical care advisors and payers. By providing them with access to real-time patient data, ResMed's solutions enable healthcare professionals to monitor their patients' progress remotely, identify potential issues, and intervene when necessary. This remote patient monitoring capability not only improves the efficiency of care but also reduces the need for in-person visits, ultimately lowering costs for both patients and the healthcare system. In addition, ResMed's digital health initiatives align with the broader industry trends towards value-based care. By providing comprehensive clinical data, the company supports payers in assessing the efficacy of treatment options and making informed decisions about coverage and reimbursement. This data-driven approach helps optimize resource allocation, ensuring that patients receive the most effective and cost-efficient care. Overall, ResMed's strategic focus on digital health and its commitment to leveraging technology for patient-centered care have positioned the company at the forefront of the respiratory care device industry. With its strong presence in the Americas and other key markets, ResMed is well-equipped to capitalize on the growing demand for sleep apnea solutions and continue driving innovation in the field of respiratory care.

Website: https://www.resmed.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1346 peers in sector

Metric RMD Sector median Vs. industry
P/E 17.98 20.10 ↓ Below average
EPS 10.37 USD -1.14 USD ↑ Above average
Dividend yield 1.22% 0.00% ↑ Above average
Profit margin 27.44% 0.00% ↑ Above average
ROE 25.25% -58.84% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is ResMed?
ResMed, a leading global company in the respiratory care device industry, has been a key player in the treatment of sleep apnea. With a focus on developing and supplying flow generators, masks, and accessories, the company has contributed significantly to addressing the growing demand for sleep apnea solutions. One of the factors driving the growth of the sleep apnea market is the increasing diagnosis of this condition. As awareness improves and medical advancements are made, more individuals are being diagnosed with sleep apnea, creating a larger customer base for companies like ResMed. Furthermore, the ageing population and the rising prevalence of obesity are also significant contributors to the increasing demand for respiratory care devices. As these demographic factors continue to shape the global healthcare landscape, ResMed is well-positioned to benefit from the structurally growing market. Geographically, ResMed generates the majority of its revenue from the Americas, which accounts for about two-thirds of its total earnings. However, it also has a significant presence in other regions, especially Europe, Japan, and Australia. This distribution of revenue across multiple regions enables the company to diversify its risk and take advantage of different market dynamics and opportunities around the globe. To stay ahead of the competition and meet the evolving needs of patients, ResMed has been actively focusing on digital health solutions. Recognizing the significance of technological advancements and the value they bring to the healthcare industry, ResMed has made strategic developments and acquisitions in the digital health space. By leveraging digital technologies, the company aims to differentiate itself by providing comprehensive and actionable clinical data that can be utilized by patients, medical care advisors, and payers in the out-of-hospital setting. ResMed's efforts in the digital health space are aimed at enhancing patient care and improving treatment outcomes. By incorporating digital solutions into their respiratory care devices, the company enables patients to track their progress, monitor their therapy, and gain insights into their sleep patterns. This self-management approach empowers patients to take an active role in managing their condition, leading to better adherence and overall health outcomes. Moreover, ResMed's digital health initiatives also benefit medical care advisors and payers. By providing them with access to real-time patient data, ResMed's solutions enable healthcare professionals to monitor their patients' progress remotely, identify potential issues, and intervene when necessary. This remote patient monitoring capability not only improves the efficiency of care but also reduces the need for in-person visits, ultimately lowering costs for both patients and the healthcare system. In addition, ResMed's digital health initiatives align with the broader industry trends towards value-based care. By providing comprehensive clinical data, the company supports payers in assessing the efficacy of treatment options and making informed decisions about coverage and reimbursement. This data-driven approach helps optimize resource allocation, ensuring that patients receive the most effective and cost-efficient care. Overall, ResMed's strategic focus on digital health and its commitment to leveraging technology for patient-centered care have positioned the company at the forefront of the respiratory care device industry. With its strong presence in the Americas and other key markets, ResMed is well-equipped to capitalize on the growing demand for sleep apnea solutions and continue driving innovation in the field of respiratory care.
Are ResMed shares expensive?
The price-to-earnings (P/E) ratio of ResMed is 17.98 — the share price is 17.98 times the annual profit per share. That is lower than the typical company in the same industry (industry median: 20.10). This is information, not a recommendation. (as of 2026-06-02)
How big is ResMed?
The market capitalization of ResMed — the combined value of all its shares — is 27.04 B USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does ResMed pay dividends?
The dividend yield of ResMed is 1.22% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does ResMed belong to?
ResMed operates in the Healthcare sector, industry: Medical Instruments & Supplies.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120